Annual Operating Profit
-$29.63 M
+$1.01 M+3.29%
December 31, 2023
Summary
- As of February 25, 2025, MBRX annual operating income is -$29.63 million, with the most recent change of +$1.01 million (+3.29%) on December 31, 2023.
- During the last 3 years, MBRX annual operating profit has fallen by -$9.89 million (-50.09%).
- MBRX annual operating profit is now -663.10% below its all-time high of -$3.88 million, reached on December 31, 2016.
Performance
MBRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$7.13 M
-$950.00 K-15.36%
September 30, 2024
Summary
- As of February 25, 2025, MBRX quarterly operating income is -$7.13 million, with the most recent change of -$950.00 thousand (-15.36%) on September 30, 2024.
- Over the past year, MBRX quarterly operating profit has stayed the same.
- MBRX quarterly operating profit is now -2122.74% below its all-time high of -$321.00 thousand, reached on March 31, 2016.
Performance
MBRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$28.92 M
-$1.19 M-4.28%
September 30, 2024
Summary
- As of February 25, 2025, MBRX TTM operating income is -$28.92 million, with the most recent change of -$1.19 million (-4.28%) on September 30, 2024.
- Over the past year, MBRX TTM operating profit has stayed the same.
- MBRX TTM operating profit is now -8908.10% below its all-time high of -$321.00 thousand, reached on March 31, 2016.
Performance
MBRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
MBRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.3% | 0.0% | 0.0% |
| 3 y3 years | -50.1% | -11.3% | +6.4% |
| 5 y5 years | -97.2% | -11.3% | +6.4% |
MBRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.0% | +3.3% | -37.1% | +21.5% | -25.9% | +9.4% |
| 5 y | 5-year | -69.1% | +3.3% | -104.2% | +21.5% | -65.0% | +9.4% |
| alltime | all time | -663.1% | +3.3% | -2122.7% | +21.5% | -8908.1% | +9.4% |
Moleculin Biotech Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.13 M(+15.4%) | -$28.92 M(+4.3%) |
| Jun 2024 | - | -$6.18 M(-7.4%) | -$27.73 M(-0.8%) |
| Mar 2024 | - | -$6.68 M(-25.1%) | -$27.95 M(-5.7%) |
| Dec 2023 | -$29.63 M(-3.3%) | -$8.92 M(+50.0%) | -$29.63 M(+6.7%) |
| Sep 2023 | - | -$5.95 M(-7.2%) | -$27.76 M(-10.2%) |
| Jun 2023 | - | -$6.41 M(-23.3%) | -$30.90 M(-3.2%) |
| Mar 2023 | - | -$8.35 M(+18.5%) | -$31.92 M(+4.2%) |
| Dec 2022 | -$30.64 M(+33.4%) | -$7.05 M(-22.4%) | -$30.64 M(+6.4%) |
| Sep 2022 | - | -$9.08 M(+22.2%) | -$28.80 M(+11.3%) |
| Jun 2022 | - | -$7.43 M(+5.1%) | -$25.87 M(+8.0%) |
| Mar 2022 | - | -$7.07 M(+35.9%) | -$23.95 M(+4.3%) |
| Dec 2021 | -$22.97 M(+16.3%) | -$5.21 M(-15.5%) | -$22.97 M(+8.0%) |
| Sep 2021 | - | -$6.16 M(+11.6%) | -$21.26 M(+0.0%) |
| Jun 2021 | - | -$5.52 M(-9.4%) | -$21.25 M(+2.3%) |
| Mar 2021 | - | -$6.09 M(+74.2%) | -$20.77 M(+5.2%) |
| Dec 2020 | -$19.74 M | -$3.50 M(-43.2%) | -$19.74 M(-6.3%) |
| Sep 2020 | - | -$6.15 M(+22.2%) | -$21.06 M(+8.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2020 | - | -$5.03 M(-0.6%) | -$19.42 M(+7.8%) |
| Mar 2020 | - | -$5.06 M(+5.2%) | -$18.02 M(+2.8%) |
| Dec 2019 | -$17.52 M(+16.6%) | -$4.81 M(+6.8%) | -$17.52 M(+2.8%) |
| Sep 2019 | - | -$4.51 M(+24.1%) | -$17.05 M(+12.7%) |
| Jun 2019 | - | -$3.63 M(-20.5%) | -$15.13 M(-10.8%) |
| Mar 2019 | - | -$4.57 M(+5.4%) | -$16.96 M(+12.9%) |
| Dec 2018 | -$15.03 M(+73.6%) | -$4.34 M(+67.4%) | -$15.02 M(+6.7%) |
| Sep 2018 | - | -$2.59 M(-52.5%) | -$14.08 M(+1.3%) |
| Jun 2018 | - | -$5.46 M(+107.0%) | -$13.89 M(+42.4%) |
| Mar 2018 | - | -$2.64 M(-22.3%) | -$9.75 M(+12.7%) |
| Dec 2017 | -$8.65 M(+122.8%) | -$3.39 M(+41.1%) | -$8.65 M(+29.6%) |
| Sep 2017 | - | -$2.40 M(+82.1%) | -$6.68 M(+17.2%) |
| Jun 2017 | - | -$1.32 M(-14.0%) | -$5.69 M(+11.7%) |
| Mar 2017 | - | -$1.53 M(+8.3%) | -$5.10 M(+31.3%) |
| Dec 2016 | -$3.88 M | -$1.42 M(-0.4%) | -$3.88 M(+57.4%) |
| Sep 2016 | - | -$1.42 M(+96.4%) | -$2.47 M(+136.1%) |
| Jun 2016 | - | -$724.00 K(+125.5%) | -$1.04 M(+225.5%) |
| Mar 2016 | - | -$321.00 K | -$321.00 K |
FAQ
- What is Moleculin Biotech annual operating income?
- What is the all time high annual operating profit for Moleculin Biotech?
- What is Moleculin Biotech annual operating profit year-on-year change?
- What is Moleculin Biotech quarterly operating income?
- What is the all time high quarterly operating profit for Moleculin Biotech?
- What is Moleculin Biotech quarterly operating profit year-on-year change?
- What is Moleculin Biotech TTM operating income?
- What is the all time high TTM operating profit for Moleculin Biotech?
- What is Moleculin Biotech TTM operating profit year-on-year change?
What is Moleculin Biotech annual operating income?
The current annual operating profit of MBRX is -$29.63 M
What is the all time high annual operating profit for Moleculin Biotech?
Moleculin Biotech all-time high annual operating income is -$3.88 M
What is Moleculin Biotech annual operating profit year-on-year change?
Over the past year, MBRX annual operating income has changed by +$1.01 M (+3.29%)
What is Moleculin Biotech quarterly operating income?
The current quarterly operating profit of MBRX is -$7.13 M
What is the all time high quarterly operating profit for Moleculin Biotech?
Moleculin Biotech all-time high quarterly operating income is -$321.00 K
What is Moleculin Biotech quarterly operating profit year-on-year change?
Over the past year, MBRX quarterly operating income has changed by $0.00 (0.00%)
What is Moleculin Biotech TTM operating income?
The current TTM operating profit of MBRX is -$28.92 M
What is the all time high TTM operating profit for Moleculin Biotech?
Moleculin Biotech all-time high TTM operating income is -$321.00 K
What is Moleculin Biotech TTM operating profit year-on-year change?
Over the past year, MBRX TTM operating income has changed by $0.00 (0.00%)